Evidence map›Paper›PMID 27471318›Full record

ArticleThe Journal of infectious diseases2016

Effect of Statin Use on Influenza Vaccine Effectiveness.

Huong Q McLean, Brian D W Chow, Jeffrey J VanWormer, Jennifer P King, Edward A Belongia

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Observational
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Huong Q McLeanCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Wisconsin.
Brian D W ChowCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Wisconsin.
Jeffrey J VanWormerCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Wisconsin.
Jennifer P KingCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Wisconsin.
Edward A BelongiaCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Wisconsin.

Funding

Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin PopulationU01IP000471 · IP · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI BELONGIA, EDWARD · 2011 to 2015
$5.6M
NCIRD CDC HHS U01 IP000471
6 · The paper itself

Abstract

backgroundRecent studies suggest that statin use may reduce influenza vaccine effectiveness (VE), but laboratory-confirmed influenza was not assessed.

methodsPatients ≥45 years old presenting with acute respiratory illness were prospectively enrolled during the 2004-2005 through 2014-2015 influenza seasons. Vaccination and statin use were extracted from electronic records. Respiratory samples were tested for influenza virus.

resultsThe analysis included 3285 adults: 1217 statin nonusers (37%), 903 unvaccinated statin nonusers (27%), 847 vaccinated statin users (26%), and 318 unvaccinated statin users (10%). Statin use modified VE and the risk of influenza A(H3N2) virus infection (P = .002) but not 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09) or influenza B virus infection (P = .2 and .4, respectively). VE against influenza A(H3N2) was 45% (95% confidence interval [CI], 27%-59%) among statin nonusers and -21% (95% CI, -84% to 20%) among statin users. Vaccinated statin users had significant protection against influenza A(H1N1)pdm09 (VE, 68%; 95% CI, 19%-87%) and influenza B (VE, 48%; 95% CI, 1%-73%). Statin use did not significantly modify VE when stratified by prior season vaccination. In validation analyses, the use of other cardiovascular medications did not modify influenza VE.

conclusionsStatin use was associated with reduced VE against influenza A(H3N2) but not influenza A(H1N1)pdm09 or influenza B. Further research is needed to assess biologic plausibility and confirm these results.

Indexed as

AgedDrug InteractionsFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesMaleMiddle AgedSeasonsVaccinationHydroxymethylglutaryl-CoA Reductase InhibitorsInfluenza Vaccinesinfluenzainfluenza vaccinestatinvaccine effectiveness

Identifiers

PMID27471318
PMCPMC5034952

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.